"Cardiologist"

During the past decade, Colorado Heart and Vascular conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Colorado Heart and Vascular" #1 sponsor was "Medtronic" with 5 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "Cardiovascular Systems Inc" with 2 trials sponsored and "Abiomed Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Colorado Heart and Vascular" #1 collaborator was "Cardiovascular Research Foundation, New York" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Alberta Innovation and Science" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Colorado Heart and Vascular" are "Heart Failure" (6 trials), "Coronary Artery Disease" (5 trials), "Atrial Fibrillation" (2 trials), "Ischemic Heart Disease" (2 trials) and "Left Ventricular Dysfunction" (2 trials). Many other conditions were trialed in "Colorado Heart and Vascular" in a lesser frequency.

Most popular intervention types in "Colorado Heart and Vascular" are "Device" (15 trials), "Other" (5 trials), "Diagnostic Test" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials), "Apixaban" (1 trials), "Arctic Front Advance Cardiac CryoAblation Catheter" (1 trials) and "Atrial Flow Regulator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Colorado Heart and Vascular" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Colorado Heart and Vascular". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Colorado Heart and Vascular, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Colorado Heart and Vascular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".